Early R-CHOP therapy assessment using FLT PET/CT in patients with DLBCL treated with R-CHOP - the initial results

被引：0
|
作者：
Malkowski, B. [1 ]
Chmielowska, E. [1 ]
Olejnik, M. [1 ]
Pietrzak, T. [1 ]
Makarewicz, A. [1 ]
Kachniarz, A. [1 ]
Kasprzak, K. [1 ]
机构：
[1] Ctr Oncol, Bydgoszcz, Poland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2011年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S250 / S251
页数：2
相关论文
共 50 条
  • [31] Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup
    Jiang, Shiyu
    Qin, Yan
    Jiang, Hongxin
    Liu, Biao
    Shi, Jianming
    Meng, Fanlu
    Liu, Peng
    Yang, Jianliang
    Yang, Sheng
    He, Xiaohui
    Zhou, Shengyu
    Gui, Lin
    Liu, Hao
    Lin, Jing
    Han Han-Zhang
    Shi, Yuankai
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (09) : 2611 - 2620
  • [32] Correlation of bcl-6 expression with response to R-CHOP in DLBCL
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2006, 7 (02): : 104 - 105
  • [33] Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study
    Winter, Jane N.
    Weller, Edie A.
    Horning, Sandra J.
    Krajewska, Maryla
    Variakojis, Daina
    Habermann, Thomas M.
    Fisher, Richard I.
    Kurtin, Paul J.
    Macon, William R.
    Chhanabhai, Mukesh
    Felgar, Raymond E.
    Hsi, Eric D.
    Medeiros, L. Jeffrey
    Weick, James K.
    Reed, John C.
    Gascoyne, Randy D.
    BLOOD, 2006, 107 (11) : 4207 - 4213
  • [34] HIV STATUS DOES NOT INFLUENCE THE OUTCOME OF PATIENTS DIAGNOSED WITH DLBCL TREATED WITH R-CHOP IN THE HAART ERA
    Coutinho, R.
    Flook, M.
    Pria, A.
    Gandhi, S.
    Bailey, K.
    Fields, P.
    Cwynarski, K.
    Wilson, A.
    Burns, F.
    Tenant-Flowers, M.
    Marcus, R.
    Orkin, C.
    Gribben, J.
    Montoto, S.
    Bower, M.
    HAEMATOLOGICA, 2013, 98 : 129 - 129
  • [35] CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies
    Ayed, Ayed O.
    Chiappella, Annalisa
    Pederson, Levi
    Laplant, Betsy R.
    Congiu, Angela Giovanna
    Gaidano, Gianluca
    Spina, Michele
    Re, Alessandro
    Cavallo, Federica
    Musuraca, Gerardo
    Macon, William R.
    Witzig, Thomas
    Vitolo, Umberto
    Nowakowski, Grzegorz S.
    BLOOD CANCER JOURNAL, 2018, 8
  • [36] Response: Outcomes with R-CHOP in DLBCL leave ample room for improvement
    Winter, Jane N.
    Weller, Edie A.
    Horning, Sandre J.
    Gascoyne, Randy D.
    BLOOD, 2007, 109 (02) : 844 - 844
  • [37] Tucidinostat/R-CHOP Combo Appears Effective, Safe in DLBCL Subtype
    不详
    ONCOLOGY-NEW YORK, 2024, 38 (07):
  • [38] Aprepitant does not alter prednisolone pharmacokinetics in patients treated with R-CHOP
    Maie, K.
    Okoshi, Y.
    Takaiwa, N.
    Kurita, N.
    Hasegawa, Y.
    Homma, M.
    Ishii, K.
    Kohda, Y.
    Chiba, S.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 298 - 299
  • [39] Perforation of the small intestine as an early complication of R-CHOP immunochemotherapy in patients with DLBCL - a report of two cases
    Bojo, Marcin
    Kalinka-Warzocha, Ewa
    Blasinska-Morawiec, Maria
    ONCOLOGY IN CLINICAL PRACTICE, 2013, 9 (02): : 84 - 87
  • [40] Combination of everolimus with R-CHOP (ever R-CHOP) as an initial therapy for diffuse large B-cell lymphoma (DLBCL): A phase I and feasibility study (NCCTG N1085 [Alliance]).
    Johnston, Patrick B.
    LaPlant, Betsy
    Nowakowski, Grzegorz S.
    Micallef, Ivana N. M.
    Ansell, Stephen Maxted
    Habermann, Thomas Matthew
    Colgan, Joseph
    Witzig, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345